• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Alimera Sciences, Inc. (ALIM)

    -NasdaqGM
    5.73 0.33(6.11%) Dec 18, 4:00PM EST
    Add to Portfolio
    Prev Close:5.40
    Open:5.45
    Bid:5.50 x 1000
    Ask:6.10 x 500
    1y Target Est:11.00
    Beta:2.94
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:5.40 - 5.77
    52wk Range:3.75 - 8.44
    Volume:400,538
    Avg Vol (3m):400,531
    Market Cap:253.82M
    P/E (ttm):N/A
    EPS (ttm):-1.11
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ALIM

    Comparison

    Symbol% ChgMkt Cap
    ALIMUp 6.11%253.82M
    AGN63.21B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):31.40
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.80
    Quarterly EPS Est (Dec-14) :-0.16
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Alimera Sciences, Inc., a biopharmaceutical company, is engaged in the research, development, and commercialization of prescription ophthalmic pharmaceuticals. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback